• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about NYSE:NNVC

Recent news which mentions NYSE:NNVC

NanoViricides updates progress on Phase 1a/1b clinical trial of antiviral drug candidate NV-387
November 29, 2023
Tags NYSE:NNVC
From News Direct
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
September 27, 2023
Tickers AZN GSK PFE SNY
Tags NYSE:NNVC
From News Direct
NanoViricides progressing well with new Covid study
August 31, 2023
Tags NYSE:NNVC
From News Direct
SARS-CoV-2 Is Not Done Yet — Could This New Drug In Clinical Trials Be The Safest Option For Treating COVID-19?
July 19, 2023
Tickers GILD MRK PFE
Tags NYSE:NNVC
From News Direct
NanoViricides testing oral gummy and syrup Covid-19 treatment - Proactive Research Analyst
July 13, 2023
Tags NYSE:NNVC
From News Direct
Novel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials – What Other Viruses Could This COVID Treatment Target?
July 11, 2023
Tickers GILD MRK PFE
Tags NYSE:NNVC
From News Direct
NanoViricides Inc. (NYSE American: NNVC) Begins Long-Awaited Clinical Trials For Its Anti-Viral Nanomedicine NV-CoV-2, Oral, Amid Continuing Need For COVID Treatment
July 06, 2023
Tickers GILD MRK PFE
Tags NYSE:NNVC
From News Direct
NanoViricides take big step forward beginning trials on its antiviral drug NV-CoV-2
June 29, 2023
Tags NYSE:NNVC
From News Direct
NanoViricides using unique technology platform to fight against viruses
April 12, 2023
Tags NYSE:NNVC
From News Direct
COVID Remains A Global Threat – NanoViricides Set To Begin Clinical Trials For Pan-Coronavirus Drug To Help Defeat COVID Once And For All
March 31, 2023
Tickers AZN GILD MRK MRNA
Tags NYSE:NNVC
From News Direct
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
March 20, 2023
Tickers GILD MRK MRNA NVAX
Tags NYSE:NNVC
From News Direct
With Nearly 20,000 Americans Still Hospitalized, COVID Remains A Threat – NanoViricides Gets Ready To Begin Clinical Trials For The World To Defeat It
March 08, 2023
Tickers NNVC
Tags NYSE:NNVC
From News Direct
This Company Is Looking For A Monkeypox Drug As City Investigates Deaths
October 27, 2022
Tickers NNVC
Tags NYSE:NNVC
From News Direct
NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly
September 19, 2022
Tickers CTLT GILD SIGA
Tags NYSE:NNVC
From News Direct
Monkeypox Is Popping Up In Places It Shouldn’t But NanoViricides Says It May Have A Solution
August 10, 2022
Tickers SIGA
Tags NYSE:NNVC
From News Direct
What Is a ‘News Pending’ Halt? What to Know as NNVC Stock Captivates Investors
September 21, 2021
Tickers NNVC
Tags NNVC NYSE:NNVC Today's Market
From InvestorPlace
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap